97 related articles for article (PubMed ID: 11020284)
1. Deriving a quantitative chirality measure from molecular similarity indices.
Benigni R; Cotta-Ramusino M; Gallo G; Giorgi F; Giuliani A; Varì MR
J Med Chem; 2000 Oct; 43(20):3699-703. PubMed ID: 11020284
[TBL] [Abstract][Full Text] [Related]
2. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a neural net-based QSAR algorithm (PCANN) with Hologram- and multiple linear regression-based QSAR approaches: application to 1,4-dihydropyridine-based calcium channel antagonists.
Viswanadhan VN; Mueller GA; Basak SC; Weinstein JN
J Chem Inf Comput Sci; 2001; 41(3):505-11. PubMed ID: 11410024
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship studies on some series of calcium channel blockers.
Gupta SP; Veerman A; Bagaria P
Mol Divers; 2004; 8(4):357-63. PubMed ID: 15612639
[TBL] [Abstract][Full Text] [Related]
5. QSAR study of 1,4-dihydropyridine calcium channel antagonists based on gene expression programming.
Si HZ; Wang T; Zhang KJ; Hu ZD; Fan BT
Bioorg Med Chem; 2006 Jul; 14(14):4834-41. PubMed ID: 16580211
[TBL] [Abstract][Full Text] [Related]
6. Enantiomeric separation by HPLC of 1,4-dihydropyridines with vancomycin as chiral selector.
Boatto G; Nieddu M; Faedda MV; de Caprariis P
Chirality; 2003 Jun; 15(6):494-7. PubMed ID: 12774288
[TBL] [Abstract][Full Text] [Related]
7. Application of ab initio theory to QSAR study of 1,4-dihydropyridine-based calcium channel blockers using GA-MLR and PC-GA-ANN procedures.
Hemmateenejad B; Safarpour MA; Miri R; Taghavi F
J Comput Chem; 2004 Sep; 25(12):1495-503. PubMed ID: 15224393
[TBL] [Abstract][Full Text] [Related]
8. QSAR and classification study of 1,4-dihydropyridine calcium channel antagonists based on least squares support vector machines.
Yao X; Liu H; Zhang R; Liu M; Hu Z; Panaye A; Doucet JP; Fan B
Mol Pharm; 2005; 2(5):348-56. PubMed ID: 16196487
[TBL] [Abstract][Full Text] [Related]
9. QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road ahead.
Mager PP; Coburn RA; Solo AJ; Triggle DJ; Rothe H
Drug Des Discov; 1992 Jul; 8(4):273-89. PubMed ID: 1445993
[TBL] [Abstract][Full Text] [Related]
10. Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.
Arhancet GB; Woodard SS; Dietz JD; Garland DJ; Wagner GM; Iyanar K; Collins JT; Blinn JR; Numann RE; Hu X; Huang HC
J Med Chem; 2010 May; 53(10):4300-4. PubMed ID: 20408553
[TBL] [Abstract][Full Text] [Related]
11. Modeling calcium channel antagonistic activity of dihydropyridine derivatives using QTMS indices analyzed by GA-PLS and PC-GA-PLS.
Mohajeri A; Hemmateenejad B; Mehdipour A; Miri R
J Mol Graph Model; 2008 Apr; 26(7):1057-65. PubMed ID: 17959402
[TBL] [Abstract][Full Text] [Related]
12. Comparison between neural networks (NN) and principal component analysis (PCA): structure activity relationships of 1,4-dihydropyridine calcium channel antagonists (nifedipine analogues).
Takahata Y; Costa MC; Gaudio AC
J Chem Inf Comput Sci; 2003; 43(2):540-4. PubMed ID: 12653519
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.
El-Moselhy TF; Sidhom PA; Esmat EA; El-Mahdy NA
Chem Pharm Bull (Tokyo); 2017; 65(10):893-903. PubMed ID: 28966273
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
15. [Development of desulfated chondroitin sulfate C as a novel chiral selector in capillary electrophoresis and enantioseparation of cilnidipine].
Du Y; Di B; Chen J; Zheng Z
Se Pu; 2004 Jul; 22(4):382-5. PubMed ID: 15709415
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Application of the Hansch analysis method.
Hemmateenejad B; Miri R; Akhond M; Shamsipur M
Arch Pharm (Weinheim); 2002 Dec; 335(10):472-80. PubMed ID: 12506395
[TBL] [Abstract][Full Text] [Related]
17. Different pharmacological properties of the optical isomers of MN9202, a novel 1,4-dihydropyridine Ca+ channel modulator, in rat ventricular myocytes.
Li XQ; Cao W; Zeng AG; Yang ZF; Xing B; Dong L; Zhang HF; Mei QB
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):817-25. PubMed ID: 20374262
[TBL] [Abstract][Full Text] [Related]
18. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
[TBL] [Abstract][Full Text] [Related]
19. First Organocatalytic Asymmetric Synthesis of 1-Benzamido-1,4-Dihydropyridine Derivatives.
Auria-Luna F; Marqués-López E; P Herrera R
Molecules; 2018 Oct; 23(10):. PubMed ID: 30347659
[TBL] [Abstract][Full Text] [Related]
20. Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists.
Peri R; Padmanabhan S; Rutledge A; Singh S; Triggle DJ
J Med Chem; 2000 Jul; 43(15):2906-14. PubMed ID: 10956198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
